Hyperandrogenism induces proportional changes in the expression of Kiss-1, Tac2, and DynA in hypothalamic KNDy neurons.
Androgen
Hypothalamus
Kisspeptin
Prolactin
Testosterone
Journal
Reproductive biology and endocrinology : RB&E
ISSN: 1477-7827
Titre abrégé: Reprod Biol Endocrinol
Pays: England
ID NLM: 101153627
Informations de publication
Date de publication:
21 Jun 2022
21 Jun 2022
Historique:
received:
28
12
2021
accepted:
07
06
2022
entrez:
21
6
2022
pubmed:
22
6
2022
medline:
24
6
2022
Statut:
epublish
Résumé
Kisspeptin released from Kiss-1 neurons in the hypothalamus plays an essential role in the control of the hypothalamic-pituitary-gonadal axis by regulating the release of gonadotropin-releasing hormone (GnRH). In this study, we examined how androgen supplementation affects the characteristics of Kiss-1 neurons. We used a Kiss-1-expressing mHypoA-55 cell model that originated from the arcuate nucleus (ARC) of the mouse hypothalamus. These cells are KNDy neurons that co-express neurokinin B (NKB) and dynorphin A (DynA). We stimulated these cells with androgens and examined them. We also examined the ARC region of the hypothalamus in ovary-intact female rats after supplementation with androgens. Stimulation of mHypoA-55 cells with 100 nM testosterone significantly increased Kiss-1 gene expression by 3.20 ± 0.44-fold; testosterone also increased kisspeptin protein expression. The expression of Tac3, the gene encoding NKB, was also increased by 2.69 ± 0.64-fold following stimulation of mHypoA-55 cells with 100 nM testosterone. DynA gene expression in these cells was unchanged by testosterone stimulation, but it was significantly reduced at the protein level. Dihydrotestosterone (DHT) had a similar effect to testosterone in mHypoA-55 cells; kisspeptin and NKB protein expression was significantly increased by DHT, whereas it significantly reduced DynA expression. In ovary-intact female rats, DTH administration significantly increased the gene expression of Kiss-1 and Tac3, but not DynA, in the arcuate nucleus. Exogenous NKB and DynA stimulation failed to modulate Kiss-1 gene expression in mHypoA-55 cells. Unlike androgen stimulation, prolactin stimulation did not modulate kisspeptin, NKB, or DynA protein expression in these cells. Our observations imply that hyperandrogenemia affects KNDy neurons and changes their neuronal characteristics by increasing kisspeptin and NKB levels and decreasing DynA levels. These changes might cause dysfunction of the hypothalamic-pituitary-gonadal axis.
Sections du résumé
BACKGROUND
BACKGROUND
Kisspeptin released from Kiss-1 neurons in the hypothalamus plays an essential role in the control of the hypothalamic-pituitary-gonadal axis by regulating the release of gonadotropin-releasing hormone (GnRH). In this study, we examined how androgen supplementation affects the characteristics of Kiss-1 neurons.
METHODS
METHODS
We used a Kiss-1-expressing mHypoA-55 cell model that originated from the arcuate nucleus (ARC) of the mouse hypothalamus. These cells are KNDy neurons that co-express neurokinin B (NKB) and dynorphin A (DynA). We stimulated these cells with androgens and examined them. We also examined the ARC region of the hypothalamus in ovary-intact female rats after supplementation with androgens.
RESULTS
RESULTS
Stimulation of mHypoA-55 cells with 100 nM testosterone significantly increased Kiss-1 gene expression by 3.20 ± 0.44-fold; testosterone also increased kisspeptin protein expression. The expression of Tac3, the gene encoding NKB, was also increased by 2.69 ± 0.64-fold following stimulation of mHypoA-55 cells with 100 nM testosterone. DynA gene expression in these cells was unchanged by testosterone stimulation, but it was significantly reduced at the protein level. Dihydrotestosterone (DHT) had a similar effect to testosterone in mHypoA-55 cells; kisspeptin and NKB protein expression was significantly increased by DHT, whereas it significantly reduced DynA expression. In ovary-intact female rats, DTH administration significantly increased the gene expression of Kiss-1 and Tac3, but not DynA, in the arcuate nucleus. Exogenous NKB and DynA stimulation failed to modulate Kiss-1 gene expression in mHypoA-55 cells. Unlike androgen stimulation, prolactin stimulation did not modulate kisspeptin, NKB, or DynA protein expression in these cells.
CONCLUSIONS
CONCLUSIONS
Our observations imply that hyperandrogenemia affects KNDy neurons and changes their neuronal characteristics by increasing kisspeptin and NKB levels and decreasing DynA levels. These changes might cause dysfunction of the hypothalamic-pituitary-gonadal axis.
Identifiants
pubmed: 35729637
doi: 10.1186/s12958-022-00963-w
pii: 10.1186/s12958-022-00963-w
pmc: PMC9210811
doi:
Substances chimiques
Androgens
0
Kiss1 protein, rat
0
Kisspeptins
0
Tachykinins
0
Gonadotropin-Releasing Hormone
33515-09-2
Testosterone
3XMK78S47O
Dynorphins
74913-18-1
Neurokinin B
86933-75-7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
91Informations de copyright
© 2022. The Author(s).
Références
Elife. 2016 Aug 23;5:
pubmed: 27549338
Expert Rev Endocrinol Metab. 2019 Mar;14(2):131-143
pubmed: 30767580
Front Neuroendocrinol. 2005 Apr;26(1):7-26
pubmed: 15862182
Med Sci (Basel). 2019 Nov 27;7(12):
pubmed: 31783681
J Neuroendocrinol. 2022 Feb;34(2):e13050
pubmed: 34708466
J Neurosci. 2010 Feb 24;30(8):3124-32
pubmed: 20181609
Endocrinology. 2005 Sep;146(9):3686-92
pubmed: 15919741
Gynecol Obstet Invest. 2013;75(4):268-74
pubmed: 23571154
Biol Reprod. 2012 May 10;86(5):149, 1-12
pubmed: 22337333
J Neuroendocrinol. 2014 Dec;26(12):898-908
pubmed: 25207795
Hum Reprod Update. 2014 Jul-Aug;20(4):485-500
pubmed: 24615662
Adv Exp Med Biol. 2013;784:275-95
pubmed: 23550011
Front Endocrinol (Lausanne). 2018 Apr 24;9:184
pubmed: 29740399
Endocrinology. 2017 Feb 1;158(2):367-377
pubmed: 27983870
Endocr Rev. 2015 Oct;36(5):487-525
pubmed: 26426951
Neuroendocrinology. 2018;106(2):195-202
pubmed: 28866668
Int J Gynaecol Obstet. 2018 Aug;142(2):162-169
pubmed: 29745981
Mol Endocrinol. 2016 Feb;30(2):217-33
pubmed: 26726951
Brain Res. 2012 Jul 27;1467:1-9
pubmed: 22668987
J Neurosci. 2009 Sep 23;29(38):11859-66
pubmed: 19776272
J Endocrinol. 2006 Mar;188(3):387-96
pubmed: 16522719
Biol Reprod. 2018 Dec 1;99(6):1216-1226
pubmed: 29961889
Endocrinology. 2013 Jan;154(1):434-45
pubmed: 23183180
Nat Genet. 2009 Mar;41(3):354-358
pubmed: 19079066
Endocrinology. 2010 Aug;151(8):3479-89
pubmed: 20501670
Biotechniques. 2005 Jul;39(1):75-85
pubmed: 16060372
J Reprod Dev. 2007 Apr;53(2):367-78
pubmed: 17213691
Endocrinology. 2014 Mar;155(3):1010-20
pubmed: 24456164
Endocrinology. 2007 Aug;148(8):3781-91
pubmed: 17495003
J Mol Endocrinol. 2005 Jun;34(3):597-601
pubmed: 15956331
Endocrinology. 2015 Apr;156(4):1441-52
pubmed: 25643156
Endocrinology. 2004 Jun;145(6):2959-67
pubmed: 14988383
Clin Med Insights Reprod Health. 2019 Sep 09;13:1179558119871921
pubmed: 31523136
Mol Cell Endocrinol. 2021 Jan 1;519:111042
pubmed: 33010309
J Postgrad Med. 2019 Jan-Mar;65(1):18-23
pubmed: 30004037
Hum Reprod. 2020 Jun 1;35(6):1421-1431
pubmed: 32510130
Endocrinol Metab (Seoul). 2015 Jun;30(2):124-41
pubmed: 26194072
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3334-E3343
pubmed: 28320971
J Neuroendocrinol. 2010 Oct;22(10):1101-12
pubmed: 20673302
Endocrine. 2014 Nov;47(2):631-8
pubmed: 24752393
Hum Reprod Update. 2018 Nov 1;24(6):694-709
pubmed: 30059968